These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 345811)

  • 1. Real-time B-scan-directed amniocentesis.
    Platt LD; Manning FA; Lemay M
    Am J Obstet Gynecol; 1978 Mar; 130(6):700-3. PubMed ID: 345811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preventability of "bloody taps" in second trimester amniocentesis by ultrasound scanning.
    Kerenyi TD; Walker B
    Obstet Gynecol; 1977 Jul; 50(1):61-4. PubMed ID: 876524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound placental site in relation to bloody taps in midtrimester amniocentesis.
    Hohler CW; Doherty RA; Lea J; Newhouse J; Felix J
    Obstet Gynecol; 1978 Nov; 52(5):555-7. PubMed ID: 724173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amniotic fluid concentrations of collagenase-1 and collagenase-3 are increased in polyhydramnios.
    Fortunato SJ; Menon R; Ahmed NU; Bourgeois M; Dildy GA
    J Perinat Med; 2004; 32(2):122-5. PubMed ID: 15085886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five hundred cases of amniocentesis without bloody tap.
    Katayama KP; Roesler MR
    Obstet Gynecol; 1986 Jul; 68(1):70-3. PubMed ID: 3523332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of amniocentesis guided by real-time ultrasonic tomography.
    Hisanaga S; Shimokawa H; Matsuo T; Umezu T; Maesato S; Kashiwabara Y; Nakano H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):981-4. PubMed ID: 6875349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of amniocentesis performed between weeks 9 and 16 of gestation: its feasibility, risks, complications and use in early genetic prenatal diagnosis.
    Elejalde BR; de Elejalde MM; Acuña JM; Thelen D; Trujillo C; Karrmann M
    Am J Med Genet; 1990 Feb; 35(2):188-96. PubMed ID: 2309757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meconium staining of amniotic fluid at midtrimester amniocentesis.
    Karp LE; Schiller HS
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):47s-49s. PubMed ID: 876542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative management of second-trimester post-amniocentesis fluid leakage.
    Gold RB; Goyert GL; Schwartz DB; Evans MI; Seabolt LA
    Obstet Gynecol; 1989 Nov; 74(5):745-7. PubMed ID: 2812651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amniocentesis following premature rupture of fetal membranes and suspected premature rupture of fetal membranes in late pregnancy].
    Schmidt R; Rabe D; Leucht W; Schmidt W
    Geburtshilfe Frauenheilkd; 1988 Jan; 48(1):29-31. PubMed ID: 3350324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the ultrasound aspiration transducer in midtrimester amniocentesis.
    Farahani G; Goldman MA; Davis JG; Kardon NB; Mohandes E; Pek H; Fenton AN
    J Reprod Med; 1984 Apr; 29(4):227-31. PubMed ID: 6201613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esterase activity in second- and third-trimester amniotic fluid: an indicator of chorioamnionitis.
    Hoskins IA; Katz J; Ordorica SA; Young BK
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1543-5. PubMed ID: 2603908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimizing the risk of amniocentesis for prenatal diagnosis.
    Goldstein AI; Dumars KW
    JAMA; 1977 Mar; 237(13):1336-8. PubMed ID: 402491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographically monitored amniocentesis to decrease intraoperative complications.
    Romero R; Jeanty P; Reece EA; Grannum P; Bracken M; Berkowitz R; Hobbins JC
    Obstet Gynecol; 1985 Mar; 65(3):426-30. PubMed ID: 3883268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous rupture of fetal membranes after amniocentesis.
    Teramo K; Sipinen S
    Obstet Gynecol; 1978 Sep; 52(3):272-5. PubMed ID: 703981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amniotic fluid insulin testing in gestational diabetes: safety and acceptance of amniocentesis.
    Haeusler MC; Konstantiniuk P; Dorfer M; Weiss PA
    Am J Obstet Gynecol; 1998 Oct; 179(4):917-20. PubMed ID: 9790370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of ultrasound in evaluating problems and complications of genetic amniocentesis.
    McArdle CR; Cohen W; Nickerson C; Hann LE
    J Clin Ultrasound; 1983 Oct; 11(8):427-9. PubMed ID: 6417171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of opaque discolored amniotic fluid at second-trimester amniocentesis.
    Hess LW; Anderson RL; Golbus MS
    Obstet Gynecol; 1986 Jan; 67(1):44-6. PubMed ID: 3940336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal loss rate after second trimester amniocentesis at different gestational age.
    Saltvedt S; Almström H
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):10-4. PubMed ID: 9926885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.